NLRP3 and neoplasm: In EG7-OVA tumor-bearing mice, CpG/ZANPs exhibited remarkable tumor suppression through concurrent NLRP3 inflammasome activation and cGAS-STING-dependent type I interferon (IFN) production, effectively overcoming conventional alum’s Th1 response limitations [89].